Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.006 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |